CD22 ligation inhibits downstream B cell receptor signaling and Ca²⁺ flux upon activation

Abstract

These findings are consistent with the concept of targeting CD22 to raise the threshold of BCR activation, which could offer therapeutic benefit in patients with autoimmune diseases.